ACE Report Cover
Local bone and hydroxyapatite graft versus ICBG for transforaminal lumbar interbody fusion
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
SPINE
Local bone and hydroxyapatite graft versus ICBG for transforaminal lumbar interbody fusion .

Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF)

Eur Spine J. 2017 Nov;26(11):2835-2842
Contributing Authors

NH vonderHoeh A Voelker CE Heyde

50 patients scheduled for transforaminal lumbar interbody fusion due to degenerative lumbar disease between L1 and S2 were included in this study to compare outcomes between different bone grafting materials. Patients were randomized to receive an autologous iliac crest bone graft or a mixture of hydroxyapatite combined with autologous bone from decompression sites. Fusion and clinical outcomes were measured over a 12-month follow-up. The fusion rate was similar between the different bone grafting materials at 12 months, both reporting an 83% fusion rate based on CT criteria. Both groups demonstrated significant improvements in VAS pain and disability (ODI), however, there were no differences between groups.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Local bone and hydroxyapatite graft versus ICBG for transforaminal lumbar interbody fusion. ACE Report. 2018;7(1):22. Available from: https://myorthoevidence.com/AceReport/Show/local-bone-and-hydroxyapatite-graft-versus-icbg-for-transforaminal-lumbar-interbody-fusion

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report